Goal2QuitVaping for Nicotine Vaping Cessation Among Adolescents
Development and Evaluation of a Brief Behavioral Activation Mobile Application for Nicotine Vaping Cessation Among Adolescent Primary Care Patients
2 other identifiers
interventional
106
1 country
1
Brief Summary
The purpose of this study is to evaluate a mobile application (app) called "Goal2QuitVaping" to help adolescents quit vaping nicotine. Goal2QuitVaping was developed by our research team to assist with quitting vaping. Participants will be randomly assigned to either download the mobile app, "Goal2QuitVaping", or not. If provided with Goal2QuitVaping, participants will be asked to use the app regularly, at least once per day, throughout the study duration. Participants will be asked to complete electronic questionnaire measures throughout the study period. Participation in this study will take about 4 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedFirst Submitted
Initial submission to the registry
June 25, 2021
CompletedFirst Posted
Study publicly available on registry
July 6, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 24, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 21, 2023
CompletedResults Posted
Study results publicly available
June 7, 2024
CompletedAugust 21, 2024
July 1, 2024
2 years
June 25, 2021
April 4, 2024
July 30, 2024
Conditions
Outcome Measures
Primary Outcomes (5)
Mean Score of Depressive Symptoms
Patients will self report depressive symptoms weekly for 4 weeks via the Beck Depression Inventory-II. The range of scores possible are 0 - 63, where lower scores are indicative of lower symptoms of depression. This outcome will measure change from baseline at week 4.
Up to 4 weeks
Average Vapes Per Day at Week 4
Assessed using the Timeline Followback during each weekly assessment. Average vapes per day at week 4.
Week 4
E-cigarette Dependence
Assessed at baseline via the 10-item Penn State Electronic Cigarette Dependence Index (ECDI). Change from baseline at week 4. The scores range from 0-20 with 0-3= not dependent, 4-8 low dependence, 9-12 medium dependence, 13+ = high dependence.
Up to 4 weeks
Number/Duration of Quit Attempts
Assessed during the Timeline Followback. Total number of quit attempts across all 4 weeks
Across all 4 weeks
7-day Point Prevalence Abstinence
Assessed during the Timeline Followback. At any point during the study across all 4 weeks.
At any point during the study
Study Arms (2)
Goal2QuitVaping
EXPERIMENTALParticipants in the Goal2QuitVaping group will be asked to download the Goal2QuitVaping app to their smartphone. Goal2QuitVaping focuses on mood management as well as on quitting vaping nicotine. Participants will be asked to use Goal2QuitVaping regularly, at least once per day, for the study duration. Participants will also be asked to complete questionnaires weekly for 4 weeks.
Treatment as Usual
OTHERParticipants in the treatment as usual group will be provided with educational material about quitting vaping nicotine and it will be suggested that they discuss any questions about mood management and about quitting vaping with their primary care provider. The educational material is from the National Cancer Institute's SmokeFree Teen website and includes information on recognizing reasons for quitting vaping, avoiding dual use of e-cigarettes and other tobacco products, setting a quit date, understanding triggers, and accessing social support.
Interventions
Goal2QuitVaping focuses on tracking daily activities, recording daily mood, and identifying new activities to complete that may help improve mood. Participants will be asked to complete questionnaire measures weekly for 4 weeks following study enrollment.
Participants will be provided educational material about quitting vaping nicotine with the suggestion to discuss questions with their PCP. Participants will be asked to complete questionnaire measures weekly for 4 weeks following study enrollment.
Eligibility Criteria
You may qualify if:
- age 16-20
- vaped nicotine on ≥20 days out of the last 30
- elevated depressive symptoms, defined as a score of ≥10 on Patient Health Questionnaire-8 (PHQ-8) during preliminary screening and the Adolescent Patient Health Questionnaire-9 (PHQ-9A) at final eligibility
- currently own an iOS or Android smartphone
- report willingness to utilize an app for quitting vaping nicotine (response of "yes" on yes/no item)
- have a valid e-mail address that is checked regularly or regular access to text messages (for follow-up assessments)
- ability to read the consent form
- has been seen (in person or remotely) by a primary care physician within the last year
You may not qualify if:
- smoked cigarettes or used other tobacco products on ≥9 days out of the last 30
- severe visual impairment
- currently receiving treatment for vaping or tobacco use
- current suicidal ideation, defined as a response ≥1 on item nine of the PHQ-9A or ≥2 on item 9 of the BDI-II
- household member currently enrolled in the study
- inability to read the consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of South Carolinalead
- National Institutes of Health (NIH)collaborator
- National Institute on Drug Abuse (NIDA)collaborator
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Jennifer Dahne
- Organization
- MUSC
Study Officials
- PRINCIPAL INVESTIGATOR
Jennifer Dahne, PhD
Medical University of South Carolina
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 25, 2021
First Posted
July 6, 2021
Study Start
June 1, 2021
Primary Completion
May 24, 2023
Study Completion
June 21, 2023
Last Updated
August 21, 2024
Results First Posted
June 7, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share